Government Agencies FDA

More

  • Twitter

    Today starts a two-day FDA public hearing in Washington, DC on biopharma and social media. I decided not to go because talking heads in a meeting room just don't make for good TV. And this is just the first step in what is no doubt going to be a very long, involved policy-making process. But as it turns out, it looks like it might have been futile for me to try to attend anyway.

  • Disgraced financier Bernard Madoff's longtime auditor has entered a guilty plea in a federal court in Manhattan.

  • Amgen

    New York Attorney General Andrew Cuomo and 14 other states are filing a lawsuit against Amgen, alleging that the biotech company was offering kickbacks to medical providers to increase the sale of its anemia drug Aranesp.

  • FDA

    The Smart Choices nutrition labeling program, created voluntarily by nine large U.S. manufacturers, is halting after federal regulators said such systems could mislead consumers, officials with the labeling group said Friday.

  • David Einhorn

    A recent court ruling that forced two ratings companies to defend fraud claims is a "game-changer" for the industry, said David Einhorn, head of Greenlight Capital.

  • tax_notice.jpg

    A global crackdown on bank secrecy and offshore tax havens is gaining steam due to  the worldwide financial crisis, the head of the OECD told CNBC.

  • stanford_allen.jpg

    The industry self-regulatory organization that was supposed to police the brokers at the Stanford Financial Group acknowledges it received a tip from an employee in 2003 that the company was running a Ponzi scheme, but did not follow up on it because of the agency's own policy.

  • stanford_allen.jpg

    Several banks, including two in the U.S., face new scrutiny as investors and regulators try to sort out the alleged Stanford Ponzi scheme, CNBC has learned. At issue: what the banks and regulators knew about massive deposits and withdrawals from Stanford over the years.

  • Accused fraudster Allen Stanford once claimed a net worth of more than $2 billion. But with all of his assets frozen by a federal judge, he has no funds to pay his high-powered criminal defense lawyer, Dick DeGuerin of Houston.

  • Shingles image from Zostavax.com

    Recently, Merck came out with the first vaccine for shingles called Zostavax. But it had manufacturing and supply issues that hurt the launch. In its earnings press release today, Merck says as of last month it has "resumed normal shipping schedules for Zostavax."

  • Sonia Sotomayor, as nominee for US Supreme Court Justice.

    Though Sonia Sotomayor is widely expected to win confirmation to the US Supreme Court, the business community is still wondering just what kind of justice she'll be

  • lilly_hq.jpg

    I was wrong. I'd blogged a few times that I thought the FDA might have a problem with "Effient," Eli Lilly's proposed name for its bloodthinner, because it was too close to efficient and all the connotations that would have.

  • Nestle is no longer under investigation by the Food and Drug Administration after tests revealed the E.coli strain found in Nestle’s cookie dough last month was not the cause of over 70 recent illnesses, the Wall Street Journal reported.

  • Perhaps reflecting concerns about the size and growth of the market for HPV shots and GSK's late entry, investors are not enthusiastic about the prestigious publication of the company's robust new test results. As I write this, GSK shares are the biggest percentage loser in big pharma.

  • Zyban Prescribing Information

    Today the Food and Drug Administration announced that Pfizer's Chantix and GlaxoSmithKline's Zyban will carry new warnings about mental side effects. Not just any old warnings, but so-called "Black Box" warnings. Or, at least, that's what we in the news media used to call them. Until the FDA called us out today.

  • Nestle Toll House

    So tell me, who doesn't like to eat the chocolate chip cookie batter before it's baked? But some folks are learning the hard way that it's not a great idea. And Nestle is paying the price.

  • Doctor examines a man at a public health center set up to check for swine flu symptoms

    Concerned over the surge of phony swine flu treatments hawked on the Internet, the Food and Drug Administration has ordered dozens of Web site operators to stop making fraudulent claims, leading to a drop in the number of scams.

  • Tobacco

    Historic anti-smoking legislation sped to final congressional passage on Friday— after a bitter fight lasting nearly a half-century— and lawmakers and the White House quickly declared it would save the lives of thousands of smokers of all ages.

  • Tobacco

    The Senate has voted to give the government extensive new powers to decide how tobacco companies will make and market their products. Supporters say that could spare millions from smoking addiction and premature death.

  • An Indiana money manager is set to plead guilty to charges of crashing an airplane near a Panhandle neighborhood in a botched attempt to fake his own death.